There are 2137 resources available
219P - Relationship among PDL1, androgen receptor (AR) and tumour infiltrating lymphocytes (TILs) in early triple negative breast cancer
Presenter: Luis Felipe Sánchez-Cousido
Session: E-Poster Display
Resources:
Abstract
220P - Annotating MammaPrint and BluePrint gene profile to the Hallmarks of cancer and understanding the biology of MammaPrint extreme risk groups
Presenter: Josien Haan
Session: E-Poster Display
Resources:
Abstract
221P - Long-term outcomes of patients with node-negative, ≤3cm, HER2+ breast cancer (BC) enrolled in ALTTO
Presenter: Daniel Eiger
Session: E-Poster Display
Resources:
Abstract
222P - Rates of cardiac adverse events in older versus younger adults receiving trastuzumab for HER2-positive early breast cancer: Results from 931 patients treated at The Royal Marsden
Presenter: Nicolò Matteo Luca Battisti
Session: E-Poster Display
Resources:
Abstract
223P - Safety and tolerability of subcutaneous trastuzumab (H SC) self-administered at home via single-use injection device (SID) in patients (pts) with HER2-positive early breast cancer (EBC): Primary and final analysis of the open-label, phase IIIB HOMERUS study
Presenter: Albert ten Tije
Session: E-Poster Display
Resources:
Abstract
224P - Neoadjuvant pyrotinib plus trastuzumab, docetaxel, and carboplatin in patients with HER2-positive early breast cancer: A single-group, multicenter, phase II study
Presenter: Zhenzhen Liu
Session: E-Poster Display
Resources:
Abstract
225P - Phase II study of pyrotinib plus albumin-bound paclitaxel and trastuzumab as neoadjuvant treatment in HER2-positive early or locally advanced breast cancer
Presenter: Ting Luo
Session: E-Poster Display
Resources:
Abstract
226P - Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study
Presenter: Chiara Molinelli
Session: E-Poster Display
Resources:
Abstract
227P - Cardiotoxicity in HER2 positive breast cancer patients treated with trastuzumab
Presenter: Mariana Lopez
Session: E-Poster Display
Resources:
Abstract
228P - Pathologic response to neoadjuvant antiher2 therapy in HER2 equivocal overexpression with FISH amplification
Presenter: Serafin Morales
Session: E-Poster Display
Resources:
Abstract